Zoledronic acid reduces recurrence risk in women with EBC

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1641, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid reduces fracture risk . . .

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Zoledronic acid reduces skeletal complications in prostate cancer

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 32-38

Bentham Science Publishers

Access to resources Recommend Favorite

Zoledronic Acid

By Cheer S.M. Noble S.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 799-805

Adis International

Access to resources Recommend Favorite

Zoledronic acid

By Coleman Robert Burkinshaw Roger Winter Matthew Neville-Webbe Helen Lester Jim Woodward Emma Brown Janet

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 133-145

Informa Healthcare

Access to resources Recommend Favorite